Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #915 on Eiger BioPharmaceuticals Inc (EIGRQ)
Pink Current
12/16/15 7:09 AM
#917 RE: Marilynt #915
is a press release issued by Eiger on December 15, 2015 entitled “Eiger BioPharmaceuticals Announces Notice of Allowance for U.S. Patent Covering Bestatin™ (Ubenimex) for the Treatment of Pulmonary Arterial Hypertension.”